Explore
Validate
Learn17905-1-AP
antibody from Proteintech Group
Targeting: LPCAT4
AGPAT7, AYTL3, FLJ10257, LPAAT-eta, LPEAT2
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 17905-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#17905-1-AP, RRID:AB_2140478
- Product name
- LPCAT4 antibody
- Antibody type
- Polyclonal
- Description
- LPCAT4 antibody (Cat. #17905-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Overexpression of lysophospholipid acyltransferase, LPLAT10/LPCAT4/LPEAT2, in the mouse liver increases glucose-stimulated insulin secretion.
Upregulation of LPGAT1 Enhances Lung Adenocarcinoma Proliferation.
Deep multilayer brain omics identifies the potential involvement of menopause molecular networks in Gliomas' disease progression.
iPLA2β knockout mouse, a genetic model for progressive human motor disorders, develops age-related neuropathology.
Lysophosphatidylcholine acyltransferase 1 altered phospholipid composition and regulated hepatoma progression.
Shimizu K, Ono M, Mikamoto T, Urayama Y, Yoshida S, Hase T, Michinaga S, Nakanishi H, Iwasaki M, Terada T, Sakurai F, Mizuguchi H, Shindou H, Tomita K, Nishinaka T
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2024 Jan 31;38(2):e23425
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2024 Jan 31;38(2):e23425
Upregulation of LPGAT1 Enhances Lung Adenocarcinoma Proliferation.
Gong H, Ma C, Li X, Zhang X, Zhang L, Chen P, Wang W, Hu Y, Huang T, Wu N, Wang X
Frontiers in bioscience (Landmark edition) 2023 May 11;28(5):89
Frontiers in bioscience (Landmark edition) 2023 May 11;28(5):89
Deep multilayer brain omics identifies the potential involvement of menopause molecular networks in Gliomas' disease progression.
Liu C, Zhang W, Xu G, Zhang D, Zhang C, Qiao S, Wang Z, Wang H
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2022 Oct;36(10):e22570
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2022 Oct;36(10):e22570
iPLA2β knockout mouse, a genetic model for progressive human motor disorders, develops age-related neuropathology.
Blanchard H, Taha AY, Cheon Y, Kim HW, Turk J, Rapoport SI
Neurochemical research 2014 Aug;39(8):1522-32
Neurochemical research 2014 Aug;39(8):1522-32
Lysophosphatidylcholine acyltransferase 1 altered phospholipid composition and regulated hepatoma progression.
Morita Y, Sakaguchi T, Ikegami K, Goto-Inoue N, Hayasaka T, Hang VT, Tanaka H, Harada T, Shibasaki Y, Suzuki A, Fukumoto K, Inaba K, Murakami M, Setou M, Konno H
Journal of hepatology 2013 Aug;59(2):292-9
Journal of hepatology 2013 Aug;59(2):292-9
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The LPCAT4 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human LPCAT4. This antibody recognizes human, mouse, rat antigen. The LPCAT4 antibody has been validated for the following applications: ELISA, WB analysis.
